Evidence map›Paper›PMID 35106636›Full record

ReviewApplied microbiology and biotechnology2022

Inhibitory activities of grape bioactive compounds against enzymes linked with human diseases.

Vagish Dwibedi, Sahil Jain, Divya Singhal, Anuradha Mittal, Santosh Kumar Rath, Sanjai Saxena

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Phytochemical Profiling and Biological Evaluation ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vagish DwibediUniversity Institute of Biotechnology, Chandigarh University, Mohali, Punjab, 140413, India.
Sahil JainUniversity Institute of Biotechnology, Chandigarh University, Mohali, Punjab, 140413, India.
Divya SinghalUniversity Institute of Biotechnology, Chandigarh University, Mohali, Punjab, 140413, India.
Anuradha MittalUniversity Institute of Biotechnology, Chandigarh University, Mohali, Punjab, 140413, India.
Santosh Kumar RathDepartment of Pharmaceutical Chemistry, Danteswari College of Pharmacy, Borpadar, Jagdalpur, Chhattisgarh, 494221, India. skrath1985@gmail.com.ORCID http://orcid.org/0000-0001-8557-9450
Sanjai SaxenaDepartment of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, Punjab, 147001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A quest for identification of novel, safe and efficient natural compounds, as additives in the modern food and cosmetic industries, has been prompted by concerns about toxicity and side effects of synthetic products. Plant phenolic compounds are one of the most documented natural products due to their multifarious biological applications. Grape (Vitis vinifera) is an important source of phenolic compounds such as phenolic acids, tannins, quinones, coumarins and, most importantly, flavonoids/flavones. This review crisply encapsulates enzyme inhibitory activities of various grape polyphenols towards different key human-ailment-associated enzymes: xanthine oxidase (gout), tyrosinase (hyperpigmentation), α-amylase and α-glucosidase (diabetes mellitus), pancreatic lipase (obesity), cholinesterase (Alzheimer's disease), angiotensin i-converting enzymes (hypertension), α-synuclein (Parkinson's disease) and histone deacetylase (various diseases). The review also depicts the enzyme inhibitory mechanism of various grape polyphenols and briefly discusses their stature as potential therapeutic and drug development candidates. KEY POINTS: • Nineteen major bioactive polyphenols from the grape/grape products and their disease targets are presented • Sixty-two important polyphenols as enzyme inhibitors from grape/grape products are presented • A thorough description and graphical presentation of biological significance of polyphenols against various diseases.

Indexed as

VitisAntioxidantsFlavonoidsHumansPlant ExtractsPolyphenolsAntioxidantsFlavonoidsPlant ExtractsPolyphenolsEnzyme inhibitorsGrape coumarinsGrape flavonoidsGrape polyphenolsNatural anti-oxidantsPhenolic compounds

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.